Pancreatic cancer in 2015: Precision medicine in pancreatic cancer-fact or fiction?

Nature Reviews Gastroenterology and Hepatology

Volumn 13, Issue 2, 2016, Pages 74-75

  Seufferlein, Thomas ^a   Mayerle, Julia ^b  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b UNIVERSITY OF GREIFSWALD   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GLYPICAN 1; BIOLOGICAL MARKER;

CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; DISEASE MARKER; EPIGENETICS; EXOSOME; GENE EXPRESSION; HUMAN; NONHUMAN; PANCREAS ADENOMA; PANCREAS CANCER; PERSONALIZED MEDICINE; PRIORITY JOURNAL; SHORT SURVEY; SURVIVAL RATE; TUMOR GROWTH; TUMOR MICROENVIRONMENT; PANCREATIC NEOPLASMS;

BIOMARKERS; HUMANS; PANCREATIC NEOPLASMS;

EID: 84956746682     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2015.215     Document Type: Short Survey

References (10)

1. Rahib, L. et al. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res. 74, 2913-2921 (2014).
2. Gui, J. C. et al. CA19-9 and CA242 as tumor markers for the diagnosis of pancreatic cancer: a meta-analysis. Clin. Exp. Med. 14, 225-233 (2014).
3. Poruk, K. E. et al. The clinical utility of CA 19-9 in pancreatic adenocarcinoma: diagnostic and prognostic updates. Curr. Mol. Med. 13, 340-351 (2013).
4. Ghatnekar, O. et al. Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature. Int. J. Cancer 133, 2392-2397 (2013).
5. Melo, S. A. et al. Glypican-1 identifies cancer exosomes and detects early pancreatic cancer. Nature 523, 177-182 (2015).
6. Zill, O. A. et al. Cell-free DNA next-generation sequencing in pancreatobiliary carcinomas. Cancer Discov. 5, 1040-1048 (2015).
7. Gentles, A. J. et al. The prognostic landscape of genes and infiltrating immune cells across human cancers. Nat. Med. 21, 938-945 (2015).
8. Moffitt, R. A. et al. Virtual microdissection identifies distinct tumor-and stroma-specific subtypes of pancreatic ductal adenocarcinoma. Nat. Genet. 47, 1168-1178 (2015).
9. Boj, S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324-338 (2015).
10. Huang, L. et al. Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell-and patient-derived tumor organoids. Nat. Med. 21, 1364-1371 (2015).